Therapeutic Delivery – Products

Product News
Aptamer Group Extends Collaboration With AstraZeneca To Explore Next-Generation Drug Delivery Approaches
Aptamer Group has announced the extension of their current agreement with AstraZeneca. This agreement will further the existing collaboration to evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of developing next-generation drug delivery vehicles, Optimer-drug conjugates.

Product News
ViaCyte and Gore Expand Collaboration
ViaCyte, Inc., and W. L. Gore & Associates, Inc., have announced an expanded joint development agreement covering the development and use of Gore materials and device capabilities to further optimize ViaCyte's product candidates for the treatment of diabetes.

Product News
CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics
Cybin Inc. today announced the signing of a definitive agreement to acquire 100% of the shares in Adelia Therapeutics Inc.

Product News
First In Vivo CRISPR Treatment Delivered Intravenously to a Patient
Intellia Therapeutics, Inc announced that the first patient has been treated with NTLA-2001, which the company is developing as a single-course, potentially curative therapy for transthyretin amyloidosis (ATTR).

Product News
Novavax COVID-19 Vaccine Granted Fast Track Designation
Novavax, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate.

Product News
Bruker’s 1 GHz NMR Spectrometer To Advance UK High-Field Solid-State NMR National Research Facility
Bruker today announces that its 1 GHz nuclear magnetic resonance (NMR) spectrometer has been delivered to the UK’s National Research Facility for High-Field Solid-State NMR at the University of Warwick.

Product News
BioChromato Invest In International Markets
BioChromato Inc. has made a major investment to expand sales, marketing and customer support activities in international markets, most notably Europe and North America.

Product
Advertisement
Visualize ASO, miRNA, or siRNA with miRNAscope™

Product News
Tailored Solutions for Exosome-related Research
AMSBIO is offering a comprehensive range of end-to-end services for exosome purification, characterization, and engineering.

Product News
TALLC Granted UK Patent for SmartCelle Ocular Drug Delivery Technology
TALLC has announced that the United Kingdom Intellectual Property Office (IPO) has granted the first in a series of SmartCelle smart micelle patents covering their novel nanotechnology for ocular drug delivery.
Advertisement